Free Trial

EUROFINS SCIENT (OTCMKTS:ERFSF) Shares Down 4.7% - Time to Sell?

EUROFINS SCIENT logo with Medical background

Key Points

  • EUROFINS SCIENT shares fell by 4.7% to $72.22, with trading volume down 80% from the average.
  • Analysts maintain a "Hold" rating on the stock, with one analyst assigning a Strong Buy rating.
  • The company has a debt-to-equity ratio of 0.77, indicating moderate leverage in its financial structure.
  • MarketBeat previews top five stocks to own in November.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s stock price dropped 4.7% during trading on Friday . The company traded as low as $72.22 and last traded at $72.22. Approximately 298 shares traded hands during trading, a decline of 80% from the average daily volume of 1,485 shares. The stock had previously closed at $75.82.

Wall Street Analyst Weigh In

Separately, Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold".

Check Out Our Latest Report on ERFSF

EUROFINS SCIENT Trading Down 2.7%

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The stock has a 50 day moving average price of $76.14 and a 200-day moving average price of $68.26.

About EUROFINS SCIENT

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUROFINS SCIENT Right Now?

Before you consider EUROFINS SCIENT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.

While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.